Keytruda is a cancer immunotherapy drug that belongs to a class called checkpoint inhibitors. It works by blocking a protein called PD-1 found on immune cells, which cancer cells use to evade detection by the immune system. By blocking PD-1, Keytruda reactivates the immune system, enabling it to identify and attack cancer cells more effectively. It is used to treat several types of cancer,...